{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:08:30Z","timestamp":1790874510340,"version":"4.1.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>Epidemiologic evidence regarding association of ovarian cancer risk with blood lipid level and hyperlipidemia is inconsistent. We aimed to synthesize available epidemiologic studies to disentangle associations of cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and hyperlipidemia with ovarian cancer risk. We searched <jats:italic toggle=\"yes\">PubMed<\/jats:italic>, <jats:italic toggle=\"yes\">EMBASE<\/jats:italic>, and <jats:italic toggle=\"yes\">Web of Science<\/jats:italic> for eligible studies. A random-effects model was applied for synthesis. Heterogeneity was evaluated by a Chi-squared test for the Cochran <jats:italic toggle=\"yes\">Q<\/jats:italic> statistic and the <jats:italic toggle=\"yes\">I<\/jats:italic>-squared value. Subgroup analysis was conducted by design, study locale, and ovarian cancer case number. Sensitivity analysis was conducted for studies adjusting for certain covariates or with superior quality. To explore the potential dose\u2013response relationship, we further synthesized effect measures of moderate levels of cholesterol, triglycerides, HDL-C, and LDL-C. Twelve studies (five cohort and seven case-control studies) were included. In primary meta-analysis, the synthesized risk ratio (RR<jats:sub>pool<\/jats:sub>) and 95% confidence interval (CI) suggested that high cholesterol was associated with an increased ovarian cancer risk (RR<jats:sub>pool<\/jats:sub> 1.22, 95% CI 1.01\u20131.48, Cochran <jats:italic toggle=\"yes\">P<\/jats:italic> value: 0.40, I<jats:sup>2<\/jats:sup>: 0.5%). High HDL-C was associated with a lower ovarian cancer risk (RR<jats:sub>pool<\/jats:sub> 0.61, 95% CI 0.40\u20130.94, Cochran <jats:italic toggle=\"yes\">P<\/jats:italic> value: 0.06, I<jats:sup>2<\/jats:sup>: 63.7%). We obtained nonsignificant associations for other exposures. Subgroup and sensitivity analyses yielded consistent results as the primary analysis. Only cholesterol showed marginally significant association in synthesis using moderate exposure levels (RR<jats:sub>pool<\/jats:sub> 1.18, 95% CI 0.99\u20131.42, Cochran <jats:italic toggle=\"yes\">P<\/jats:italic> value: 0.51, I<jats:sup>2<\/jats:sup>: 0.0%). Our study suggests that high blood cholesterol is associated with an increased ovarian cancer risk, whereas the etiological significance of other exposures deserves more investigations.<\/jats:p>","DOI":"10.1097\/cej.0000000000000597","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T13:27:00Z","timestamp":1591104420000},"page":"161-170","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":37,"title":["Ovarian cancer risk in relation to blood lipid levels and hyperlipidemia: a systematic review and meta-analysis of observational epidemiologic studies"],"prefix":"10.1097","volume":"30","author":[{"given":"Dongyu","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Oncology, Georgetown University School of Medicine, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhi","family":"Xi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Feng","sequence":"additional","affiliation":[{"name":"University of Michigan Medical School, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/ije\/dyr130","article-title":"Metabolic risk factors and ovarian cancer in the metabolic syndrome and cancer project.","volume":"40","author":"Bj\u00f8rge","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ygyno.2011.06.038","article-title":"Use of metformin and the risk of ovarian cancer: a case-control analysis.","volume":"123","author":"Bodmer","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis.","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1517\/14740331003662620","article-title":"Statin use and cancer risk: a comprehensive review.","volume":"9","author":"Boudreau","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12986-017-0176-4","article-title":"Case-control study of metabolic syndrome and ovarian cancer in Chinese population.","volume":"14","author":"Chen","year":"2017","journal-title":"Nutr Metab (Lond)"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/jcm8010018","article-title":"Novel immune features of the systemic inflammation associated with primary hypercholesterolemia: changes in cytokine\/chemokine profile, increased platelet and leukocyte activation.","volume":"8","author":"Collado","year":"2018","journal-title":"J Clin Med"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.taap.2012.01.007","article-title":"Lipid raft: a floating island of death or survival.","volume":"259","author":"George","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/jnci\/88.1.32","article-title":"Prospective study of serum micronutrients and ovarian cancer.","volume":"88","author":"Helzlsouer","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.cell.2016.08.003","article-title":"Cellular cholesterol directly activates smoothened in Hedgehog signaling.","volume":"166","author":"Huang","year":"2016","journal-title":"Cell"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1503\/cmaj.060410","article-title":"The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey.","volume":"176","author":"Ioannidis","year":"2007","journal-title":"CMAJ"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10552-017-0991-y","article-title":"Serum lipids and risk of obesity-related cancers in postmenopausal women.","volume":"29","author":"Kabat","year":"2018","journal-title":"Cancer Causes Control"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0000000000000217","article-title":"Ovarian cancer: epidemiology and risk factors.","volume":"26","author":"La Vecchia","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"e20304","DOI":"10.7554\/eLife.20304","article-title":"Cholesterol activates the G-protein coupled receptor smoothened to promote Hedgehog signaling.","volume":"5","author":"Luchetti","year":"2016","journal-title":"Elife"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer.","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1074\/jbc.R114.617936","article-title":"Smoothened goes molecular: new pieces in the hedgehog signaling puzzle.","volume":"290","author":"McCabe","year":"2015","journal-title":"J Biol Chem"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1158\/1055-9965.EPI-12-0188","article-title":"Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study.","volume":"21","author":"Melvin","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ygyno.2019.08.032","article-title":"Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: an analysis of linked SEER-medicare data.","volume":"155","author":"Michels","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pop.2012.11.003","article-title":"Hyperlipidemia as a risk factor for cardiovascular disease.","volume":"40","author":"Nelson","year":"2013","journal-title":"Prim Care"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/0895-4356(90)90100-4","article-title":"Differential recall as a source of bias in epidemiologic research.","volume":"43","author":"Neugebauer","year":"1990","journal-title":"J Clin Epidemiol"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ejca.2006.11.010","article-title":"Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis.","volume":"43","author":"Olsen","year":"2007","journal-title":"Eur J Cancer"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0959-8049(97)00011-7","article-title":"Ovarian cancer risk and history of selected medical conditions linked with female hormones.","volume":"33","author":"Parazzini","year":"1997","journal-title":"Eur J Cancer"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review.","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol Med"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.coph.2012.07.002","article-title":"Cholesterol and its derivatives in sonic Hedgehog signaling and cancer.","volume":"12","author":"Riobo","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/ije\/19.1.205","article-title":"Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls.","volume":"19","author":"Rodrigues","year":"1990","journal-title":"Int J Epidemiol"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/01635581.2019.1595049","article-title":"Dietary fat intake and risk of ovarian cancer: a systematic review and dose-response meta-analysis of observational studies.","volume":"71","author":"Sadeghi","year":"2019","journal-title":"Nutr Cancer"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/DCR.0000000000001203","article-title":"Secondary breast, ovarian, and uterine cancers after colorectal cancer: a nationwide population-based cohort study in Korea.","volume":"61","author":"Shin","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1172\/JCI0216390","article-title":"Cholesterol, lipid rafts, and disease.","volume":"110","author":"Simons","year":"2002","journal-title":"J Clin Invest"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ygyno.2019.04.293","article-title":"Cardiovascular comorbidities and risk of ovarian carcinoma among African American women in the African American cancer epidemiology study (AACES).","volume":"154","author":"Staples","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0891-5849(02)01015-8","article-title":"Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide.","volume":"33","author":"Stokes","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"R33-20250527","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group.","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"R34-20250527","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018.","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R35-20250527","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1186\/s12885-019-5954-0","article-title":"Statin use and the risk of ovarian and endometrial cancers: a meta-analysis.","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Cancer"},{"key":"R36-20250527","doi-asserted-by":"crossref","first-page":"e104630","DOI":"10.1371\/journal.pone.0104630","article-title":"A prospective study of gynecological cancer risk in relation to adiposity factors: cumulative incidence and association with plasma adipokine levels.","volume":"9","author":"Wu","year":"2014","journal-title":"PLoS One"},{"key":"R37-20250527","first-page":"e920531","article-title":"Histological tumor type is associated with one-year cause-specific survival in women with stage III-IV epithelial ovarian cancer: a surveillance, epidemiology, and end results (SEER) database population study, 2004-2014.","volume":"26","author":"Wu","year":"2020","journal-title":"Med Sci Monit"},{"key":"R38-20250527","doi-asserted-by":"crossref","first-page":"792034","DOI":"10.1155\/2012\/792034","article-title":"Serum lipids and the risk of gastrointestinal malignancies in the Swedish AMORIS study.","volume":"2012","author":"Wulaningsih","year":"2012","journal-title":"J Cancer Epidemiol"},{"key":"R39-20250527","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10552-014-0507-y","article-title":"Dyslipidemia and colorectal cancer risk: a meta-analysis of prospective studies.","volume":"26","author":"Yao","year":"2015","journal-title":"Cancer Causes Control"},{"key":"R40-20250527","first-page":"1231","article-title":"A prospective analysis of circulating plasma metabolomics and ovarian cancer risk.","volume":"25","author":"Zeleznik","year":"2019","journal-title":"bioRxiv"},{"key":"R41-20250527","first-page":"1","article-title":"Inflammatory markers of CRP, IL6, TNF\u03b1, and soluble TNFR2 and the risk of ovarian cancer: a meta-analysis of prospective studies.","volume":"654962","author":"Zeng","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R42-20250527","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2016.04.543","article-title":"Is aspirin use associated with a decreased risk of ovarian cancer? A systematic review and meta-analysis of observational studies with dose-response analysis.","volume":"142","author":"Zhang","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R43-20250527","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/carcin\/bgy048","article-title":"Non-herbal tea consumption and ovarian cancer risk: a systematic review and meta-analysis of observational epidemiologic studies with indirect comparison and dose-response analysis.","volume":"39","author":"Zhang","year":"2018","journal-title":"Carcinogenesis"},{"key":"R44-20250527","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.diabres.2017.04.005","article-title":"Diabetes mellitus and risk of ovarian cancer. A systematic review and meta-analysis of 15 cohort studies.","volume":"130","author":"Zhang","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"R45-20250527","doi-asserted-by":"crossref","first-page":"e2868","DOI":"10.1002\/dmrr.2868","article-title":"Diabetes mellitus and long-term mortality of ovarian cancer patients. A systematic review and meta-analysis of 12 cohort studies.","volume":"33","author":"Zhang","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"R46-20250527","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3945\/ajcn.110.010926","article-title":"Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials.","volume":"94","author":"Zheng","year":"2011","journal-title":"Am J Clin Nutr"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:02:47Z","timestamp":1748361767000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000597","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,29]]}}}